With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...

Jan 21 (Reuters) - Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a ...

Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...

Merck's affordable Ebola vaccine initiatives, Abbott's profit challenges, U.S. vaccination policy changes under Health ...

MSD and the Coalition for Epidemic Preparedness Innovations have launched a $30 million initiative to improve the ...

SK Bioscience has joined a new international effort to advance an updated Zaire ebolavirus vaccine, following a funding agreement between the CEPI and Merck & Co.

In a statement sent to PREMIUM TIMES on Friday, CEPI said the project is designed to address long-standing challenges around the cost, supply and deployment of the vaccine, particularly in ...

SK Bioscience will accelerate the development of a next-generation Zaire Ebola vaccine with funding from the Coalition for ...

The Democratic Republic of the Congo (DRC) has declared a new Ebola outbreak in Kasai Province. It's caused by the most severe strain: Zaire Ebola virus. Filoviruses are among the globe's most ...

The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11,841 people in Guinea during 2015. Among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more ...

April 1 -- MONDAY, March 31 (HealthDay News) -- Researchers have successfully tested several Ebola vaccines in monkeys and are now working to create the first human vaccine for one of the world's ...

Johns Hopkins Bloomberg School of Public Health researchers say that major disruptions in the health care systems in West Africa caused by the Ebola crisis have led to significant decreases in ...